1. Sweden Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
Biotage AB (publ)

Biotage AB (publ)

BITGF
Biotage AB (publ)US flagOther OTC
15.01
USD
- -
- -
1.20BMarket Cap
Biotage AB (publ)
BITGF
(Other OTC)

Recent

price

15.01

P/E

ratio

- -

div

yld

- -

ROIC.AI

2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
FRC
4.47
5.14
5.49
6.32
6.53
7.58
9.43
10.32
11.56
14.08
16.9
16.75
18.85
23.73
25.21
25.68
24.5
Revenue per Share
0.15
-4.91
0.42
0.52
0.61
1
1.13
1.43
2.14
2.59
2.87
2.68
3.14
4.06
3.33
3.55
3.2
Basic EPS, GAAP
-0.03
0.31
0.86
0.47
0.23
0.75
1.36
1.41
2.03
1.67
2.55
3.34
4.54
4.11
2.61
3.05
2.35
Free Cash Flow per Basic Share
0.2
0.21
0.25
0.4
0.51
0.6
0.75
1.25
1.25
1.4
1.5
- -
1.5
1.55
1.44
1.6
1.6
Dividend per Share
13.02
7.99
8.45
8.65
8.51
9.36
9.82
10
10.89
12.08
13.37
16.06
17.67
20.04
20.18
20.61
20.66
Book Value per Share
6.27
4.25
4.44
4.27
3.62
4.44
5.06
5.3
5.96
5
4.6
6.89
4.85
8.09
6.92
9.81
9.08
Tangible Book Value per Share
88
84
78
73
68
65
65
65
65
65
65
65
65
66
74
80
80
Basic Weighted Avg Shares
394
429
428
463
445
490
611
668
748
911
1,101
1,092
1,232
1,566
1,862
2,056
1,961
Sales/Revenue/Turnover
-2.57
5.99
5.96
9.47
8.81
8.68
11.89
13.77
16.75
17.32
18.68
17.12
20.78
18.65
17.13
18.43
15.55
Operating Margin (%)
35
482
36
29
31
34
41
44
34
39
74
74
75
101
149
185
179
Depreciation Expense
13
-410
32
38
41
65
73
93
139
168
187
175
205
268
246
284
256
Net Income, GAAP
- -
- -
7.31
- -
- -
5.48
3.85
- -
- -
4.91
11.87
21.08
23.79
22.99
18.81
13.41
12.03
Effective Tax Rate (%)
3.42
-95.64
7.58
8.28
9.31
13.18
12
13.89
18.55
18.4
16.96
16.03
16.64
17.11
13.21
13.81
13.05
Profit Margin (%)
468
315
298
260
187
212
239
228
265
321
374
535
461
614
742
776
729
Working Capital
8
6
30
28
24
10
1
1
1
111
216
141
180
192
226
216
207
LT Debt
1,089
568
564
531
477
516
547
563
609
702
876
990
1,371
1,637
3,657
4,113
3,846
Total Equity
- -
- -
4.04
- -
- -
7.82
13
- -
- -
21.1
18.82
13
14.3
13.14
8.92
7.88
6.41
Return on Invested Capital (%)
- -
- -
4.79
- -
- -
10.64
11.73
- -
- -
21.18
18.91
15.3
16.15
18.77
15.61
16.37
13.42
Return on Capital (%)
1.83
-45.16
4.89
5.93
6.82
10.9
11.81
14.47
20.52
22.54
22.59
18.24
18.62
21.64
17.5
18.09
16.12
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'24
Dec'24
Mar'25
ST Debt
33
34
31
LT Borrowings
150
150
150
LT Finance Leases
67
66
57
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
80
80
80
Market Capitalization
15,122
13,187
9,279

Working Capital

FRC

•

in mil. unless spec.
Sep'24
Dec'24
Mar'25
Total Current Assets
1,238
1,358
1,204
Cash, Cash Equivalents & STI
370
434
420
Accounts Receivable, Net
310
357
247
Inventories
490
458
439
Total Current Liabilities
648
582
475
Payables & Accruals
- -
- -
- -
ST Debt
33
34
31
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
26.39%
41.37%
12.47%
Free Cash Flow
22.06%
11.24%
26.42%
Net Income, GAAP
17.06%
9.76%
15.45%
Sales/Revenue/Turnover
15.7%
13.68%
10.42%
Total Cash Common Dividend
- -
- -
20.75%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
361
409
449
643
1,862
2024
480
504
490
582
2,056
2025
385
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
0.65
0.49
0.48
1.64
3.33
2024
0.41
0.6
0.56
1.99
3.55
2025
0.05
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
1.53
- -
- -
1.44
2024
- -
1.6
- -
- -
1.6
2025
- -
- -
- -
- -
- -
Similar Companies
Akoya Biosciences, Inc. (AKYA)
Ocumetics Technology Corp. (OTCFF)
Femasys Inc. (FEMY)
AegirBio AB (publ) (AEGIR.ST)
Bloom Health Partners Inc. (BLMHF)
Supermax Corporation Berhad (7106.KL)
Business
Biotage AB (publ) Biotage AB (publ) provides solutions and products for drug discovery and development, analytical testing, and water and environmental testing; offers organic and peptide synthesis solutions, flash chromatography, evaporation, parallel peptide purification, and work-up products; supplies flash systems and accessories, normal and reversed phase cartridges, sample preparation products, plasmid purification solutions, oligo synthesis solutions, metal and supported scavengers and reagents, as well as accessories and spare parts; delivers sample preparation solutions for clinical and bioanalytical, forensic and toxicology, doping control in animals and humans, environment, and food and agriculture areas, including consumables, systems, and workflows; provides biomolecule purification solutions encompassing antibody, plasmid, AAV, and tagged proteins purification, automation systems, and custom packing services with ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company serves pharmaceutical and biotechnical companies, contract research and manufacturing organizations, academic laboratories, hospitals, police and criminal investigators, sports events, and industries in diagnostics, clinical research, environmental protection, food safety, and forensics. Biotage AB (publ) operates globally across the Americas, Asia-Pacific, Europe, the Middle East, and Africa from its headquarters in Uppsala, Sweden, where it was founded in 1969 and employs approximately 680 people. In 2025, RWK Bidco AB, a vehicle controlled by KKR through Gamma Biosciences, completes a public takeover offer, securing a 93.12% stake in the company at SEK145 per share for a total enterprise value of approximately SEK11.6 billion.